Skip to Main Content

1,684

Views

0

CrossRef citations to date

0

Altmetric

Musculoskeletal

Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia

Hana Al-Abdulkarima National Guard Health Affairs, Riyadh, Saudi Arabia;b King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia;c Doctoral School of Applied Informatics and Applied Mathematics, Óbuda University, Budapest, HungaryView further author information

,

Yuvraj Sharmad IQVIA, London, UKView further author information

,

Suzan M. Attare Rheumatology & Internal Medicine, King Abdulaziz University, Jeddah, Saudi ArabiaView further author information

,

Waleed Husainf Heraa Hospital, Makkah, Saudi ArabiaView further author information

,

Ibrahim Al-Homoodg Internal Medicine Department, King Fahad Medical City, Riyadh, Saudi ArabiaView further author information

,

Bedor Al Omarih Pharmaceutical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaView further author information

,

Omneya Mohamedi Real-World Evidence (RWE), IQVIA AG, Dubai, United Arab EmiratesView further author information

,

Mai Alsaqa’abyj Real-World Evidence (RWE), IQVIA Solutions, Riyadh, Saudi ArabiaCorrespondence[email protected]

https://orcid.org/0000-0001-8369-5044 View further author information

,

Ahmed M. Jaheenk Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi ArabiaView further author information

,

Ali Anwark Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi ArabiaView further author information

,

Tharwat M. Hamadk Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi ArabiaView further author information

&

Zeyad Alzahranil Department of Surgery, King Abdulaziz Medical City, Jeddah, Saudi ArabiaView further author information